Mineral City Biotechnologies
Website unreachable since Oct 31, 2026
Mineral City Biotech develops imaging-based solutions for surgical specialists, utilizing advanced imaging technologies to enhance preoperative planning and intraoperative navigation. This approach addresses the challenges of precision and accuracy in surgical procedures, ultimately improving patient outcomes and reducing operative risks.
- Artificial Intelligence
- Healthcare Technology
- Medical Devices
- Software Only
Funding
Raised to date
$150KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Surgical specialists face challenges in achieving optimal precision and accuracy during procedures, which can impact patient outcomes and increase operative risks. Traditional preoperative planning and intraoperative navigation methods may lack the advanced imaging capabilities needed for complex cases.
Solution
Mineral City Biotech develops imaging-based solutions designed to enhance surgical precision and accuracy. By leveraging advanced imaging technologies, the company aims to improve preoperative planning and intraoperative navigation for surgical specialists. Their solutions provide surgeons with detailed visualizations and guidance, potentially leading to improved patient outcomes and reduced operative risks. The technology assists surgeons in navigating complex anatomical structures with greater confidence.
Target Audience
The primary target audience includes surgical specialists seeking to improve precision and accuracy in their procedures.
Features
- Advanced imaging modalities for detailed preoperative planning.
- Intraoperative navigation tools to guide surgical procedures.
- Enhanced visualization of anatomical structures.